This mechanism concurrently suppresses skeletal muscle atrophy with secondary fibrosis and facilitates mutant SOD1 aggregate clearance, ultimately delaying disease progression and extending survival in ALS animal models (Wen et al., 2021). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.